COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Mimetas develops OrganoPlate organ‑on‑a‑chip systems enabling high‑throughput 3D perfused cell cultures with membrane‑free co‑culture and kidney, liver, gut, brain, oncology disease, toxicology and ADME models for pharmaceutical and chemical testing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
